Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

NCT01238809 · Status: WITHDRAWN · Type: OBSERVATIONAL · Enrollment: 7300

Last updated 2011-06-08

No results posted yet for this study

Summary

The purpose of this study is to assess in general population low-dose aspirin and gastroprotective agent compliance and reasons for bad compliance

Conditions

  • Self-administered Questionnaire to Patients

Sponsors & Collaborators

Principal Investigators

  • Mrs Genevieve BONNELYE · KantarHealth - France

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-07-31
Completion
2011-07-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01238809 on ClinicalTrials.gov